Recalls for CUBICIN (daptomycin for injection)

Cubist Pharmaceuticals Issues Voluntary Nationwide Recall of Nine Lots of CUBICIN (daptomycin for injection) 500 mg in 10 mL single use vials Following Complaints of Foreign Particulate Matter in Reconstituted Vials
08/09/2014 Food Recall

Cubist Pharmaceuticals, Inc. (NASDAQ: CBST) today announced it is voluntarily recalling nine lots of CUBICIN (daptomycin for injection) to the user level following complaints of foreign particulate matter in reconstituted vials. The administration of particulate matter, if present in an intravenous drug, poses a potential safety risk to patients such as a thromboembolism or a life-threatening pulmonary embolism.

  • Company:
    Cubist Pharmaceuticals, Inc.
  • Problem
    Elevated Calcium And Phosphorus Levels
Cubist Pharmaceuticals Issues Voluntary U.S. Recall Of Certain Lots Of CUBICIN (Daptomycin For Injection) 500 mg In 10 mL Single Use Vials Due To Presence Of Particulate Matter
08/07/2014 Food Recall

Cubist Pharmaceuticals, Inc. (NASDAQ: CBST) today announced it is voluntarily recalling certain lots of CUBICINĀ® (daptomycin for injection) to the user level due to the potential presence of glass particulate matter in vials produced by a contract manufacturer. Please click here for the list of affected CUBICIN lot information.

  • Company:
    Cubist Pharmaceuticals, Inc.
  • Problem
    Serious Injury Hazard (Recall Alert)